Clinical Trial Update: Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Genvoya (E/C/F/TAF) to Stribild (E/C/F/TDF) in ART-naive adults with HIV-1; completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• HIV Infection

Drugs mentioned

• Genvoya (elvitegravir; cobicistat; emtricitabine; tenofovir alafenamide)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2016-01-08